Acadia Healthcare Company, Inc. (NASDAQ:ACHC) PT Lowered to $48.00 at BMO Capital Markets

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) had its target price decreased by BMO Capital Markets from $52.00 to $48.00 in a research note published on Thursday, October 26th. BMO Capital Markets currently has an outperform rating on the stock.

Several other equities analysts have also recently weighed in on the company. Cantor Fitzgerald lowered their target price on Acadia Healthcare from $48.00 to $39.00 and set a neutral rating on the stock in a research note on Tuesday, October 24th. Citigroup Inc. reduced their target price on Acadia Healthcare from $61.00 to $44.00 and set a buy rating for the company in a report on Wednesday, October 25th. Zacks Investment Research downgraded Acadia Healthcare from a hold rating to a sell rating in a research report on Thursday, October 12th. William Blair started coverage on Acadia Healthcare in a research report on Tuesday, July 18th. They issued an outperform rating on the stock. Finally, Craig Hallum reiterated a buy rating and issued a $41.00 price target (down from $65.00) on shares of Acadia Healthcare in a research report on Thursday, October 26th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of $45.15.

Acadia Healthcare (NASDAQ:ACHC) opened at $28.23 on Thursday. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.36 and a current ratio of 1.36. The stock has a market capitalization of $2,480.11, a price-to-earnings ratio of 12.33, a P/E/G ratio of 1.05 and a beta of 0.89. Acadia Healthcare has a one year low of $27.88 and a one year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The company had revenue of $716.70 million during the quarter, compared to the consensus estimate of $728.86 million. During the same quarter in the previous year, the business posted $0.58 earnings per share. The business’s quarterly revenue was down 2.4% compared to the same quarter last year. analysts predict that Acadia Healthcare will post 2.23 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece of content was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://ledgergazette.com/2017/11/13/acadia-healthcare-company-inc-achc-pt-lowered-to-48-00.html.

In other Acadia Healthcare news, Director Reeve B. Waud sold 984,075 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $49,882,761.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Ronald Morgan Fincher sold 80,000 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $4,055,200.00. Following the transaction, the chief operating officer now owns 59,071 shares in the company, valued at approximately $2,994,308.99. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,824,040 shares of company stock valued at $92,460,588. Insiders own 11.10% of the company’s stock.

Large investors have recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Acadia Healthcare by 11.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after purchasing an additional 270 shares during the period. C M Bidwell & Associates Ltd. bought a new stake in Acadia Healthcare in the 2nd quarter valued at about $205,000. Riverhead Capital Management LLC bought a new stake in Acadia Healthcare in the 2nd quarter valued at about $209,000. Rathbone Brothers plc bought a new stake in Acadia Healthcare in the 3rd quarter valued at about $223,000. Finally, World Asset Management Inc bought a new stake in Acadia Healthcare during the 2nd quarter worth approximately $242,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply